Authors
Latest:
Clinical Overview: Finerenone (Kerendia) Lowers Cardiovascular Events, Chronic Kidney Disease ProgressionFinerenone is a first in class nonsteroidal mineralocorticoid receptor antagonist indicated in adults with chronic kidney disease associated with type 2 diabetes mellitus.
Latest:
Technology Can Help Ease Provider Burnout, Access to Health CareThe need for pharmacists to return to a more clinically-focused role became apparent as the COVID-19 pandemic revealed gaps in patient access to care across the country.
Latest:
Trends in Emergency Department Follow-Up ProgramsPharmacy personnel can be integrated to optimize antimicrobial use.
Latest:
Optimizing Self-Management for Outpatient Pharmacy Patients With DiabetesThe use of outpatient pharmacy protocols for glucose testing and insulin administration supplies should be expanded to assist patients in the self-management of diabetes.
Latest:
Navigating the Shadows: Understanding the Psychology and Pharmacology of Treating Postpartum DepressionA new treatment for postpartum depression has been developed with rapid onset, cutting down the time it has taken previous treatments to take effect by weeks or months.
Latest:
Wellness Support Group Shows Promise in Reducing BurnoutDiscussions are led by a variety of experienced preceptors to provide insight, strategies, and resources for pharmacy residents.
Latest:
Driving Clinical Pharmacy Development With Data-Driven Metrics and InsightsThere are no clearly defined, widely accepted clinical pharmacist metrics.
Latest:
How PBMs Can Help Rein in Drug SpendingFormulary changes, utilization management, and a lack of transparency upset a lot of members, which hides a lot of good things that pharmacy benefit managers do.
Latest:
What Pharmacists Need to Know About Omega-3 Fatty Acids and Fish Oil SupplementsMany patients turn to fish oil supplements to gain the benefits of omega-3 fatty acids, but there are important considerations pharmacists should be aware of before recommending fish oil supplements to their customers.
Latest:
Behind the Counter: Mastering Pseudoephedrine and Other Restricted OTC MedicationsMelissa Zinszer, PharmD, CDCES, explores the multifaceted role of pharmacists and healthcare providers in managing behind-the-counter medications, addressing patient concerns, optimizing over-the-counter therapy, and ensuring safe, effective treatment through careful symptom assessment and consideration of drug interactions.
Latest:
New Tool Helps Providers Navigate Adalimumab BiosimilarsThe tool consolidates and highlights key features that would be considered when choosing a biosimilar adalimumab.
Latest:
Preventing Adverse Drug Events: A Call to Action for PharmacistsNational Adverse Drug Event Awareness Day was established to promote awareness, drive policy changes, and encourage health care professionals and patients to prioritize medication safety.
Latest:
Explore Ovarian Cancer Treatments Through Clinical TrialsGuidelines typically recommend debulking surgery, plus systemic chemotherapy for most patients.
Latest:
Oral Oncolytics Expand Armamentarium in HR+/HER– Early-Stage Breast Cancer in Adjuvant SettingNew agents can offer a more tailored approach to therapy selection.
Latest:
Clinical Pharmacists Can Improve Cost Savings Through Medication Assistance Programs in Primary CarePharmacists should continue to seek out opportunities to be involved in family medicine and chronic disease state management to make meaningful impacts on care.
Latest:
Survey: Retail Pharmacists Optimistic About Biosimilars, Still Have QuestionsWith the FDA approval and launch of the first interchangeable biosimilar in the United States in 2021, retail pharmacists are poised to play an increasing role in the future uptake of biosimilars.
Latest:
Direct Oral Anticoagulant Use for Left Ventricular Thrombus TreatmentAn overview of the use of direct oral anticoagulants as an alternative to warfarin in the treatment of left ventricular thrombus.
Latest:
Three Ways Community Pharmacies Can Partner With Academia to Implement Patient Care InitiativesMany faculty members are adept at training and teaching pharmacists and pharmacy technicians how to perform physical exams and tests.
Latest:
EmPATHy: More Empathy Toward Patients Improves Outcomes in Their HealthBy empathizing with patients and creating an environment where patients feel comfortable and open to sharing, pharmacists can increase compliance and adherence.
Latest:
Commonly Overlooked Adverse Effects in the Community, Clinical Pharmacy SettingsAlthough pharmacists possess a wealth of knowledge on AEs, it remains a monumental task to recall the clinical significance of every AE, even with the most commonly used medications.
Latest:
Pediatric Weight is Crucial to Perfecting the DoseEvidence indicates that up to 25% of all prescriptions for children could be dosed inappropriately, making it the most common type of medication administration error.
Latest:
AAN 2025: Insights on Pediatric Multiple Sclerosis Treatment and ManagementLauren B. Krupp, MD, FAAN, provides comprehensive guidance on treating pediatric multiple sclerosis, emphasizing early intervention, high-efficacy therapies, and holistic family support.
Latest:
Pharmacists Help Patients Navigate Vaccine SchedulesMany patients may struggle to understand the complex immunization schedules compiled by the CDC.
Latest:
Important Treatment Considerations With LDL-C– Lowering TherapiesPanelists discuss how the initiation of statin therapy requires careful consideration of contraindications and patient-specific factors, particularly in those with liver disease, renal impairment, or advanced age, while noting evolving treatment patterns toward more intensive low-density lipoprotein cholesterol (LDL-C)–lowering therapies based on individualized risk assessment.
Latest:
AI Can Help Bridge Disparities in Cancer Care Through Digital PlatformsCollaboration between AI-based platforms and health care organizations offers promising results.
Latest:
Interactive Case Studies: September 2023Cases highlight an acute subdural hematoma and chronic obstructive pulmonary disease.
Latest:
Zongertinib: A Promising New TKI for HER2-Mutated NSCLCIf approved, zongertinib may be a new first-line oral tyrosine kinase inhibitor (TKI) for patients with HER2-mutated non-small cell lung cancer (NSCLC), a transformative step in TKI drug development.
